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Background. Intuitively, health and capability are dis-
tinct but linked concepts. This study aimed to quantify
the link between a measure of health status (EQ-5D-3L)
and capability (ICECAP-O) using regression-based meth-
ods. Methods. EQ-5D-3L and ICECAP-O data were col-
lected from a sample of older people (n = 584), aged over
65 years, requiring a hospital visit and/or care home resi-
dent, and recruited to one of 3 studies forming the Medical
Crisis in Older People (MCOP) program in England. The
link of EQ-5D-3L with 1) ICECAP-O tariff scores were esti-
mated using ordinary least squares (OLS) or censored least
absolute deviation (CLAD) regression models; and 2)
ICECAP-O domain scores was estimated using multinomial
logistic (MNL) regression. Mean absolute error (MAE), root
mean squared error (RMSE), absolute difference (AD)
between mean observed and estimated values, and the R2
statistic were used to judge model performance. Results. In
this sample of older people (n = 584), higher scores on the
EQ-5D-3L were shown to be linked with higher ICECAP-O
scores when using linear regression. An OLS-regression
model was identified to be the best performing model with
the lowest error statistics (AD = 0.0000; MAE = 0.1208;
MSE = 0.1626) and highest goodness of fit (R2 = 0.3532);
model performance was poor when predicting the lower
ICECAP-O tariff scores. The three domains of the EQ-5D-
3L showing a statistically significant quantifiable link with
the ICECAP-O tariff score were self-care, usual activities,
and anxiety/depression. Conclusion. A quantifiable, but
weak, link between health (EQ-5D-3L) and capability
(ICECAP-O) was identified. The findings from this study
add further support that the ICECAP-O is providing com-
plimentary information to the EQ-5D-3L. Mapping between
the 2 measures is not advisable and the measures should
not be used as direct substitutes to capture the impact of
interventions in economic evaluations. Key words:
regression analysis; EQ-5D-3L; ICECAP-O; capability;
health status; quality of life. (Med Decis Making
XXXX;XX:xx–xx)
Health status, captured using the quality-adjustedlife year (QALY) measure,1,2 and quantified
using generic preference-based measures,3 has
become the commonly recommended outcome to
value the consequences of healthcare programs in
economic evaluations.4 Guidance on how to perform
economic evaluations to inform resource allocation
within healthcare systems, such as the National
Institute for Health and Care Excellence (NICE)
methods guide for technology appraisal,5 has led to a
focus on using the EQ-5D5,6 as the relevant metric to
quantify the health consequences of healthcare pro-
grammes.7–9
Relevant consequences broader than health status,
as defined by the EQ-5D,3 have been suggested.10–13
Moving beyond health status may be particularly rel-
evant when valuing the consequences of complex12
and social care interventions.14 An alternative conse-
quence is the notion of capability introduced as a
concept by Sen.15–17 Sen suggested that the relevant
objective for policy-makers should be based on a
person’s ability to ‘‘do’’ or ‘‘be.’’16-20 Lorgelly21 and
Coast et al.22 provide an overview of measures that
aim to quantify capability and their potential use in
economic evaluation.
The suite of ICECAP measures are considered
useful, as they have associated preference weights,
making them viable measures of capability for use
in economic evaluations. The ICECAP measures
were the first capability-based measures designed
for use in economic evaluations.23,24 The ICECAP
suite includes the ICECAP-O (the full measure can
be downloaded from the ICECAP [University of
Birmingham] website25) for use in older people26
and ICECAP-A for adults.27 NICE guidance
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currently recommends the ICECAP measures as an
option in economic evaluation of social care inter-
ventions.28 The developers suggest that the ICECAP
measures capture the impact of a broader aspect of
quality of life rather than only health status as cap-
tured by the EQ-5D. Differences are apparent in
both the conceptualization and practical design of
the ICECAP and EQ-5D measures, respectively.
Conceptual differences are apparent in the question
wording to bring the focus of ICECAP in line with
Sen’s theoretical underpinning using the terminol-
ogy of ‘‘ability’’ rather than the focus on ‘‘function-
ing’’ seen in EQ-5D. Two practical design differ-
ences are apparent: the severity levels used (4 levels
for ICECAP v. 3 for EQ-5D-3L) and different tariff
scoring scales. Both measures use the same upper
bound score of 1, representing either ‘‘full capabil-
ity’’ or ‘‘perfect health.’’ The measures differ in how
the lower bound is anchored at zero. For ICECAP,
zero represents ‘‘no capability.’’ For EQ-5D, zero
represents a state equivalent to dead but it is also
possible to have states worse than dead with nega-
tive scores. Thus, the 2 measures operate on differ-
ent scales, with implications for their direct com-
parison. There is currently no definitive guidance
on how to use ICECAP measures in economic eva-
luation (i.e., should they be used in a QALY-based
approach or otherwise?). Even though the ICECAP
measures are preference-based, this does not mean
they could be used to quantify a QALY; although, at
least one study has chosen this path.29 Relatedly, it
is not clear that the QALY is an appropriate end-
point for evaluating capability. 30 This has led to
work on an alternative capability-based method for
economic evaluation.31 Therefore, research into
how capability should be operationalized as part of
an economic evaluation should be considered as
‘‘ongoing.’’
Sen was purposely vague in his definition of
capability.17,32 Nussbaum suggested a need for
more specificity in what is meant by capability.33,34
Grewal and colleagues35 suggested that ‘‘It is not
poor health in itself, which reduces quality of life,
but the influence of that poor health upon each
informant’s ability to, say, be independent, that is
important’’. In this context, health is perceived as a
conversion factor for capability. Capability is
viewed as the objective end-goal for patients when
receiving healthcare rather than only health status.
Available measures of health status (EQ-5D-3L) and
capability (ICECAP-O) have been argued to be con-
ceptually different,21 and a previous study has sug-
gested that the 2 measures offer complementary
information (rather than the ICECAP-O acting as a
substitute to the EQ-5D-3L, because it captures
essentially the same information).36 However, it
seems logical, based on their conceptual underpin-
ning, that health and capability could be linked in
some quantifiable way and, therefore, a change in
health captured by the EQ-5D-3L may be associated
with a change in capability captured by the
ICECAP-O.37 One study has identified that capabil-
ity (ICECAP-O) was strongly and positively associ-
ated with health status (EQ-5D-3L); however, that
study focused on a specific population of older peo-
ple receiving post-acute rehabilitation care and was
a relatively small sample (n = 82).38 The current
study aimed to build on this work and quantify the
link between the EQ-5D-3L and the ICECAP-O to
quantify the relationship (association) between the
constructs of the measures, health, and capability,
respectively.
METHODS
This study used regression-based statistical
methods to quantify the link between the EQ-5D-3L
and ICECAP-O, informed by published guidance
and recommended reporting standards for mapping
studies (also called ‘‘cross-walking’’ or ‘‘transfer to
utility’’).39–44 The ICECAP-O was used as the target
measure (response variable) for this assessment so
that the descriptive results suggest to what extent a
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change in health is associated with a change in
capability. This approach is consistent with the
conceptual idea that health is a conversion factor
for capability rather than vice versa (i.e., using the
EQ-5D-3L as the target measure).
Study Sample
Data were collected from 3 observational cohort
studies that formed the Medical Crises in Older
People (MCOP) program: Acute Medical Outcomes
Study (AMOS); Better Mental Health (BMH) study;
and Care Home Outcomes Study (CHOS).
AMOS45,46 included older people (70 y and over)
admitted to hospital and discharged within 72 h
from an Acute Medical Unit (AMU), in Nottingham
or Leicester, England. Baseline data (n = 667) were
collected at recruitment and follow-up data collected
90 d post-recruitment. Patients were excluded if staff
advised against approaching the patient, or if neither
the patient nor the carer could communicate in
English sufficiently to complete baseline assess-
ments. Patients who lacked the mental capacity to
consent to study participation were recruited pro-
vided a responsible physician gave permission.
BMH47,48 included older people (70 y and over)
with a co-morbid mental health problem; with an
unplanned admission to an acute general hospital
in Nottingham, England, lasting 2 or more days to
one of 12 named wards (trauma orthopedic, acute
geriatric medical, general medical); and who had
been screened using brief tests of cognition,49
depression,50 anxiety,51 or alcohol misuse.52
Baseline data (n = 250) were collected at recruit-
ment and follow-up data collected 180 d post-
recruitment. Patients viewed to have sufficient
mental capacity gave written informed consent.
Patients viewed to lack sufficient mental capacity
were recruited provided a family member or carer
gave permission.
CHOS53 included older people (65 y and over)
living in either a residential or nursing care home.
Eleven (6 residential and 5 nursing) care homes
within the Nottinghamshire catchment area were
recruited. Baseline data (n = 227) were collected at
recruitment and follow-up data collected at 180 d
post-recruitment. Outcomes (EQ-5D-3L; ICECAP-O)
were recorded using proxy and self-reported
approaches but the study did not record when
either approach was used. Care home managers
determined which residents had the mental capac-
ity to consent to participate, defined against the
criteria in the English Mental Capacity Act.54 If resi-
dents lacked capacity, a consultee was identified
and, if they were in favor of proceeding, the resi-
dent was enrolled.
Dataset
Data collected in all 3 studies included: age, gen-
der, whether living in a care home (nursing or resi-
dential), EQ-5D-3L, and ICECAP-O (follow-up
only). Appendix S1 details the outcome measures
collected. The analysis used ICECAP-O and EQ-5D-
3L data collected between April 2009 and February
2011.
The ICECAP-O comprises 5 attributes reflecting
capability (attachment, security, role, enjoyment, and
control), each of which has 4 levels (the full measure
can be downloaded from the ICECAP [University of
Birmingham] website25). The ICECAP-O tariff score is
anchored between 0 (no capability) and 1 (full capabil-
ity). The preference-based scoring tariff for the
ICECAP-O26 was quantified using the best–worst scal-
ing technique.55 The measure, which was specifically
designed for older people, has proven construct,37, 56-58
convergent and discriminant,59-61 and face62 validity.
The EQ-5D-3L comprises 5 attributes reflecting
health status (mobility, self-care, usual activities,
pain/discomfort, anxiety/depression), each of
which has 3 levels (the full measure can be down-
loaded from the EuroQoL website63). The UK prefer-
ence-based tariff score of the EQ-5D-3L ranges from
20.594 (a state worse than dead) to 1 (perfect
health). The value of zero is representative of the
state of dead. The UK’s preference-based scoring
tariff for the EQ-5D-3L64 was quantified using the
time–trade-off technique.65 A structured review of
the generic self-assessed health instruments sug-
gested that there is good evidence of validity (con-
struct, convergent and discriminant) for the use of
the EQ-5D-3L in older people.66
Estimation Dataset
The estimation dataset (hereafter called
‘‘MCOP’’) used data from all 3 studies combined.
The appropriateness of using this combined dataset
was tested using a linear regression model to assess
the degree of association among the data coming
from 1 of the 3 study samples and the ICECAP-O
tariff score (see Appendix S2). There was concern
that cognitive ability may need to be accounted for
within this analysis, as it could be associated with a
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given response to the ICECAP-O. A linear regression
model was used to test the degree of association
between cognitive ability (defined by Mini Mental
State Examination [MMSE] score as a continuous or
discrete dummy variable67,68) and the ICECAP-O
tariff score. This analysis indicated that being in a
particular study sample or cognitive ability (MMSE
score) did not have a statistically significant associ-
ation with the ICECAP-O tariff score.
Older people are on a continuum often character-
ized by aspects such as co-morbidities, physical
and mental health, and cognitive ability. However,
the 3 study samples are artificial groupings defined
by place of recruitment and eligibility criteria but,
overall, probably represent the continuum of older
people more than any one study sample on its own
(see also Graham et al.69 and Carlo et al.,70 which
describe this continuum in the case of prevalence of
cognitive ability in older people with and without
dementia). Therefore, the results of the statistical
analysis to inform combining these groups were not
unexpected.
Data Analysis
All analyses were carried out using Stata version
11.71 The estimation dataset (MCOP) and data from
the 3 studies were analyzed using descriptive statis-
tics and the distributions of the EQ-5D-3L and
ICECAP-O data. Regression techniques were used to
analyze the estimation dataset (MCOP) to quantify
the strength of association between the EQ-5D-3L
and ICECAP-O.
To inform the choice of regression models, the
distribution of the ICECAP-O and EQ-5D-3L were
assessed. Figure 1 shows the distribution of the EQ-
5D-3L and ICECAP-O within the estimation dataset
and illustrates that both measures had skewed and
bimodal or multimodal tariff score distributions.
Importantly, both measures were identified to have
non-normally distributed tariff scores, and ceiling
effects were apparent.
Based on this result, 3 types of regression models
were investigated to identify which was most
appropriate in terms of taking into account the type
and distribution of the ICECAP-O scores (tariff or
domain scores, as the response variable): (1) ordi-
nary least squares [OLS] or censored least absolute
deviation [CLAD] models were used to quantify the
link between overall health status (EQ-5D-3L tariff
score) or domains of health (EQ-5D-3L domain
scores) and overall capability (ICECAP-O tariff score
as a continuous variable); (2) Multinomial Logistic
[MNL] models to quantify the link between overall
health status or domains of health and domains of
capability (ICECAP-O domain scores as categorical
variables).
ICECAP-O Tariff Score as a Continuous Variable
The OLS model is a commonly used model, par-
ticularly in the context of mapping studies.39,72 On
occasion, the OLS model provides a relatively good,
if not superior, model performance compared with
alternative models.39,42,73 However, when data are
semi-continuous, which has been shown to be a
characteristic of EQ-5D-3L and ICECAP-O data,
there is evidence that OLS may not be the best
model.41,74,75 In such circumstances, the CLAD
model may be appropriate because it is robust in
the presence of heteroscedasticity and non-normal-
ity, and allows a censoring (consistent with full
capability at a tariff score of 1) at the upper end of
the data distribution.41,76
ICECAP-O Domain Scores as Categorical
Variables
The MNL model allows prediction of the domain
scores of the ICECAP-O. This additional informa-
tion could be used to describe the relationship
between health status and capability at the domain
level for both measures.42,75,77 The MNL model
assigns a probability to the likelihood of a person
reporting a particular level score for each domain of
the target measure, which is represented by the
coefficient from the MNL model. The MNL model
was estimated twice using a different number of
Monte Carlo simulations (once with 1 simulation,
once with 100 simulations) to assess the effect of
running multiple simulations on model perfor-
mance.78 Monte Carlo simulation was preferred to
other methods such as expected utility or most-
likely probability methods,79 and probabilistic map-
ping,80 because it ensured that unbiased expected
values were obtained.78 This method previously
performed relatively well in a mapping study with
the ICECAP-O as the response variable.42
Model Specifications
Ten model specifications were assessed (see
Table 1). Four of these model specifications (see
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Figure 1 Distribution of the observed tariff scores for (a) EQ5D-3L and (b) ICECAP-O for 4 datasets: (1) MCOP, (2) AMOS, (3) BMH, and
(4) CHOS.
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Table 1, Models 1, 3, 5 and 7) add covariates (age,
gender and care home [being a resident in a care
home]) in line with published recommendations,
with the aim of improving the statistical robustness
of the model.39,42,75,81
Internal Validity
The ‘‘best’’ performing model specification was
identified using tests for internal validity. ‘‘Best’’
was defined as the lowest absolute difference (AD)
between the mean observed and predicted value;
lowest mean absolute error (MAE); lowest root
mean squared error (RMSE); and highest R2 statistic.
(Note, AD biases the results to preferring OLS over
CLAD or MNL models but, given the properties and
uses of the arithmetic mean, such a bias is benefi-
cial when estimating and providing summary statis-
tics describing the relationship between health and
capability, which will include focus on the mean
value.) Internal validity was also checked by com-
paring the results from the analysis of the estima-
tion dataset (MCOP) with data from the 3 indepen-
dent study samples (AMOS; BMH; CHOS). This
analysis is classed as assessing internal, rather than
external, validity because the 3 independent sam-
ples formed the MCOP sample.
RESULTS
Table 2 shows the demographic, screening tool
(MMSE) and measure (ICECAP-O and EQ-5D-3L)
scores information for the estimation dataset. The
mean (standard deviation; SD) ICECAP-O and EQ-
5D-3L scores in the estimation dataset (MCOP) were
0.76 (0.20) and 0.53 (0.34), respectively; lower than
the mean score for the UK population over 75 y for
ICECAP-O of 0.8257 and the EQ-5D-3L of 0.73.82
The highest mean (SD) ICECAP-O score across stud-
ies was for the AMOS study, 0.80 (0.18), which also
had the relatively highest EQ-5D-3L score, 0.59
(0.30). The BMH study had a relatively higher mean
ICECAP-O score than CHOS (0.71 v. 0.67); although,
CHOS had a relatively higher mean EQ-5D-3L score
than the BMH study (0.46 v. 0.35). As observed in
Figures 1 and 2, only a small proportion of people
across and within study samples had low EQ-5D-3L
and ICECAP-O tariff scores (e.g., 33 [5.6%] people
had an ICECAP-O tariff score\0.4).
Describing the Relationship between the EQ-5D-3L
and ICECAP-O
Figure 2 shows the relationship between the EQ-
5D-3L and ICECAP-O from the estimation dataset
(MCOP). There was a positive relationship between
the measures; although, this was not obvious on
visual inspection of the scatter plot.
Quantifying the Relationship between EQ-5D-3L
and ICECAP-O
Table 3 reports the results from the different
model specifications of the estimation dataset
(MCOP). Model 7 (OLS model with EQ-5D-3L items
as discrete variables, including age, sex, and care
home explanatory variables) produced the best
model overall, with the lowest RMSE (0.1626) and
Table 1 Selected Regression Model Specifications
Model Response Variable(s) Explanatory Variable(s)
Regression model: OLS and CLAD
1 ICECAP-O tariff score EQ-5D-3L tariff score, age, gender, care home
2 ICECAP-O tariff score EQ-5D-3L tariff score
3 ICECAP-O tariff score EQ-5D-3L domain scores, age, gender, care home
4 ICECAP-O tariff score EQ-5D-3L domain scores
5 ICECAP-O tariff score EQ-5D-3L items (continuous), age, gender, care home
6 ICECAP-O tariff score EQ-5D-3L items (continuous)
7 ICECAP-O tariff score EQ-5D-3L items (discrete), age, gender, care home
8 ICECAP-O tariff score EQ-5D-3L items (discrete)
Regression model: MNL
9a ICECAP-O dimension scores EQ-5D-3L tariff score
10a ICECAP-O dimension scores EQ-5D-3L items (discrete)
aModels were run: 1) as normal; 2) using multiple simulations (100 simulations), as recommended by Gray et al.78 Both sets of results are reported
in this paper.
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highest R2 (0.3532). The lowest MAE (0.1191) was
produced by model 13 (CLAD model), which was
the best CLAD model overall but with a higher
RMSE (0.1654) and lower R2 (0.3418) than model 7.
The smallest AD was produced by each of the OLS
models (models 1, 2, 3, 4, 5, and 6), which was
intuitively correct, given that OLS is a linear mean
model. The MNL models (models 9 and 10) per-
formed worst overall across all statistics.
Table 4 reports the difference in results when the
performance statistics from the internal validation
assessment using the estimation dataset (MCOP)
were compared head-to-head with the performance
statistics from the same algorithms but when
applied to the 3 study samples independently. The
performance statistics and coefficients for the 20
regression models for the 3 independent study sam-
ples are provided in Appendix S3 and S4. This
head-to-head comparison suggested that all model
performance statistics improved in the AMOS sam-
ple compared with the estimation dataset (MCOP).
These statistics worsened within the CHOS sample
at a larger scale than any other sample (see Table 4);
across all models: MAE increased within the range
of 0.0530 to 0.0715; RMSE increased within the
range of 0.0613 to 0.0812; the R2 statistic was lower
Table 2 Descriptive Statistics for the Combined Sample (MCOP) and Sample from Three Studies
(AMOS; BMH; CHOS)
MCOP AMOS BMH CHOS
Characteristics n = 584 n = 374 n = 83 n = 127
Female, n (%) 363 (62.2%) 212 (56.7%) 51 (61.5%) 100 (78.7%)
Care home resident, n (%) 144 (24.7%) 1 (0.3%) 16 (19.3%) 127 (100%)
Cognitively impaired
(MMSE score\ 24), n (%)
182 (31.2%) 40 (10.7%) 45 (54.2 %) 97 (76%)
Mean (SD, Range)
Age 81.3 (7.1, 62–102) 79.8 (6.4, 70–99) 82.6 (6.53, 70–100) 85.12 (7.96, 62–102)
EQ-5D-3L tariff score 0.53 (0.34, 20.429–1) 0.59 (0.30, 20.429–1) 0.35 (0.40, 20.371–1) 0.46 (0.34, 20.358–1)
Mobility 1.75 (0.54, 1–3) 1.69 (0.47, 1–3) 1.82 (0.77, 1–3) 1.88 (0.53, 1–3)
Self-care 1.65 (0.74, 1–3) 1.40 (0.58, 1–3) 2.17 (0.81, 1–3) 2.05 (0.75, 1–3)
Usual activities 1.86 (0.72, 1–3) 1.83 (0.69, 1–3) 1.70 (0.71, 1–3) 2.04 (0.79, 1–3)
Pain/discomfort 1.78 (0.61, 1–3) 1.86 (0.57, 1–3) 1.87 (0.58, 1–3) 1.46 (0.64, 1–3)
Anxiety/depression 1.48 (0.57, 1–3) 1.43 (0.54, 1–3) 1.61 (0.62, 1–3) 1.54 (0.60, 1–3)
ICECAP-O tariff score 0.76 (0.20, 0–1) 0.80 (0.18, 0–1) 0.71 (0.18, 0.18–1) 0.67 (0.23, 1–4)
Attachment 3.25 (0.88, 1–4) 3.35 (0.82, 1–4) 3.16 (0.93, 1–4) 3.03 (0.96, 1–4)
Security 2.87 (0.98, 1–4) 2.90 (0.90, 1–4) 2.80 (1.10, 1–4) 2.82 (1.12, 1–4)
Role 2.65 (0.98, 1–4) 2.85 (0.89, 1–4) 2.29 (1.03, 1–4) 2.30 (1.03, 1–4)
Enjoyment 2.72 (0.90, 1–4) 2.79 (0.87, 1–4) 2.54 (0.87, 1–4) 2.62 (0.96, 1–4)
Control 2.80 (0.91, 1–4) 3.04 (0.83, 1–4) 2.60 (0.81, 1–4) 2.21 (0.91, 1–4)
MCOP, combined sample of 3 datasets for Medical Crises in Older People [program]; AMOS, dataset for Acute Medical Outcomes Study; BMH, dataset
for Better Mental Health [study]; CHOS, dataset for Care Home Outcomes Study; SD, standard deviation.
MMSE, Mini Mental State Examination. The MMSE is a screening tool for cognitive impairment,67,68 the score for which can be treated as a continuous
(ranging from zero [cognitive impairment] to 30 [cognitive normality]) or discrete variable; the latter can be based on those groupings described by
Folstein et al.67 (cognitive impairment a MMSE score\24; cognitively normal a MMSE score 24).
Figure 2 Scatter plot of the relationship between the EQ5D-3L
and ICECAP-O tariff scores for the observed dataset from MCOP.
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with this difference in statistic value being in the
range of 0.0771 to 0.2579 compared with the mod-
el’s performance in the MCOP sample.
Quantifying the Relationship between Health and
Capability
The best performing regression model was OLS
model 7. Model 7 is a linear model and this may
have implications when quantifying the relationship
between different parts of the score distribution of
the ICECAP-O. To account for this, Table 5 presents
2 performance statistics, MAE and RMSE, to show
how the best performing OLS model (7) performs
when quantifying the association for different parts
of the ICECAP-O tariff score distribution.
The overall performance of OLS model 7
resulted in an MAE of 0.1208 and an RMSE of
0.1626. The higher RMSE compared with the MAE
value was indicative of higher degrees of error
between the observed and estimated values. Table
5 shows that the size of the error between the
observed and estimated values was larger for val-
ues at the lower end of the tariff score and smaller
when the observed values were closer to the mean
value. For example, in the MCOP sample, when
the observed value for the ICECAP-O score was in
the range of 0.2 to 0.4, the MAE and RMSE were
0.3221 and 0.5162, respectively. Nearing the peak
of the distribution, when the observed ICECAP-O
tariff score was in the range of 0.6 to 0.8, the MAE
and RMSE values were 0.0877 and 0.1136, respec-
tively. This result was consistent among the 3
independent samples, where lower MAE and
RMSE values were observed within the peak of the
score distribution rather than the left-hand tail. A
quantile-quantile (Q-Q) plot to further assess the
potential bias induced by the OLS model 7 (partic-
ularly at lower level ICECAP-O tariff scores) is pro-
vided in Appendix S5.
Table 3 Internal validation (MCOP)
Observed Values Estimated Values Model Performance
Model Spec’na Number ICECAP-O Min Max ICECAP-O Min Max AD MAE RMSE R2
Regression model: OLS
1 1 584 0.7601 0 1 0.7601 0.4251 0.9342 0.0000 0.1279 0.1704 0.2787
2 2 584 0.7601 0 1 0.7601 0.4849 0.8969 0.0000 0.1334 0.1749 0.2365
3 3 584 0.7601 0 1 0.7601 0.3993 0.9246 0.0000 0.1220 0.1643 0.3336
4 4 584 0.7601 0 1 0.7601 0.4115 0.8952 0.0000 0.1233 0.1660 0.3165
5 5 584 0.7601 0 1 0.7601 0.4304 0.9370 0.0000 0.1212 0.1629 0.3456
6 6 584 0.7601 0 1 0.7601 0.4563 0.9169 0.0000 0.1224 0.1643 0.3305
7 7 584 0.7601 0 1 0.7601 0.4484 0.9396 0.0000 0.1208 0.1626 0.3532
8 8 584 0.7601 0 1 0.7601 0.4993 0.9281 0.0000 0.1221 0.1640 0.3387
Regression model: CLADb
9 1 584 0.7601 0 1 0.7831 0.4188 0.9719 0.0230 0.1253 0.1724 0.2777
10 2 584 0.7601 0 1 0.7873 0.4487 0.9557 0.0272 0.1291 0.1784 0.2365
11 3 584 0.7601 0 1 0.7766 0.3645 0.9635 0.0165 0.1204 0.1677 0.3241
12 4 584 0.7601 0 1 0.7847 0.4010 0.9456 0.0246 0.1212 0.1692 0.3118
13 5 584 0.7601 0 1 0.7824 0.4259 0.9730 0.0223 0.1191 0.1654 0.3418
14 6 584 0.7601 0 1 0.7800 0.4431 0.9560 0.0199 0.1200 0.1667 0.3261
15 7 584 0.7601 0 1 0.7838 0.3557 0.9810 0.0237 0.1200 0.1699 0.3229
16 8 584 0.7601 0 1 0.7813 0.4395 0.9624 0.0212 0.1206 0.1700 0.3138
Regression model: MNL
17 9 584 0.7601 0 1 0.7642 0.1928 1 0.0041 0.1545 0.2080 0.1109
18 9 584*100 0.7601 0 1 0.7601 0 1 0.0000 0.1629 0.2141 0.0880
19 10 584 0.7601 0 1 0.7612 0 1 0.0011 0.1467 0.1984 0.1892
20 10 584*100 0.7601 0 1 0.7605 0 1 0.0004 0.1496 0.1998 0.1703
AD, absolute difference; MAE, mean absolute error; RMSE, root mean squared error.
aAs defined in Table 1.
bCLAD regression model estimated in Stata using command as follows: clad vari, ul(1) reps(200). Seed set value: 123456789.
Numbers in bold: performed best within statistic within model; numbers in italics: performed best within statistic across models; numbers under-
lined: best model across all model performance statistics.
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The coefficients for the explanatory variables and
intercepts estimated by the best performing OLS
model 7 are presented in Table 6. Using these coef-
ficients, the following equation represents the best
performing regression model and the best estimate
of a quantified relationship between health and
capability:
Overall ICECAP-O tariff score5
1:044 0:002  age
10:009  female - 0:051  carehome
 0:016  s mo10:010  e mo
 0:081  s sc  0:159  e sc
 0:042  s ua 0:106  e ua
 0:003  s pd10:032  e pd
 0:089  s ad  0:083  e ad
These coefficients can each be interpreted as an
associative (not causal) relationship between health
and capability when we have accounted for the
effects of all other variables in the model. Not all
the estimated associations were statistically signifi-
cant (assuming statistical significance is defined at
a 5% threshold level; P \ 0.05); therefore, for
descriptive purposes, only statistically significant
relationships are now described. Moving from ‘‘no
problem’’ with self-care to: ‘‘some problem’’ is asso-
ciated with a decrease in capability of 0.081 (P =
0.000); and ‘‘extreme problem’’ is associated with a
decrease in capability of 0.159 (P = 0.000). Moving
from ‘‘no problem’’ with usual activities to ‘‘extreme
problem’’ is associated with a decrease in capability
of 0.106 (P = 0.000). Moving from ‘‘no problem’’
with anxiety/depression to: ‘‘some problem’’ is
associated with a decrease in capability of 0.089
(P = 0.000); and ‘‘extreme problem’’ is associated
with a decrease in capability of 0.083 (P = 0.030).
Living in a care home was also statistically signifi-
cantly associated with a decrease in capability of
0.051 relative to living in the community (P = 0.007).
DISCUSSION
Regression methods, synonymous with those
applied in mapping studies, were used in this study
because they provided the relevant basis to identify
the extent of the quantifiable link between 2 mea-
sures and their underlying constructs.39–44 The
results of this study suggest it was possible to quan-
tify a relationship between the EQ-5D-3L and
ICECAP-O (albeit, with large errors around the point
estimate coefficients). Results from the best per-
forming regression model (OLS model 7) suggested
that capability did have a statistically significant
relationship with some domains of health (self-care;
usual-activities; anxiety/depression), but not all
domains of health (mobility; pain/discomfort) at the
5% significance level; the small number of very
low score observations limits the extent to which a
statistically significant result could be detected,
which should be taken into account when interpret-
ing these results. This result could suggest that
ICECAP-O does not include the domains of capabil-
ity with which mobility or pain/discomfort would
have a relationship, and so would be an insensitive
measure for assessing change in capability for inter-
ventions focused on improving these aspects of
health. Alternatively, it may suggest that a change
in mobility or pain/discomfort is generally not
Table 5 MAE and RMSE of Estimated V. Observed Scores by ICECAP-O Tariff Score Groups for Best
Performing Model (OLS Model 7)
Combined Dataset Individual Datasets
ICECAP-O
MCOP AMOS BMH CHOS
Score Number % MAE RMSE Number % MAE RMSE Number % MAE RMSE Number % MAE RMSE
0\ 0.2 8 1.4 0.485 N/A 2 0.5 0.485 N/A 1 1.2 0.365 N/A 5 3.9 0.510 N/A
0.2\ 0.4 25 4.3 0.322 0.516 11 2.9 0.336 N/A 4 4.8 0.377 N/A 10 7.9 0.285 N/A
0.4\ 0.6 85 14.5 0.155 0.200 39 10.4 0.172 0.237 15 18.1 0.123 0.578 31 24.4 0.150 0.255
0.6\ 0.8 157 26.9 0.080 0.114 86 23.0 0.083 0.110 30 36.1 0.101 0.166 41 32.3 0.092 0.140
0.8\ 1 309 52.9 0.102 0.137 236 63.1 0.082 0.109 33 39.8 0.121 0.184 40 31.5 0.207 0.295
Full index 584 100 0.121 0.163 374 100 0.101 0.137 83 100 0.129 0.177 127 100 0.174 0.233
AD, absolute difference; MAE, mean absolute error; RMSE, root mean squared error; N/A, not applicable (in this instance due to the small sample
size).
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statistically significantly associated with a change
in capability. This would mean that the generalized
conceptual idea that health is a conversion factor
for capability is not true for all domains of health.
Findings from this study add further support
that the 2 constructs of health status and capability—
when quantified using EQ-5D-3L and ICECAP-O,
respectively—are complements rather than direct
substitutes for each other. Keeley et al.83 have also
explored the link between capability and health
using a different capability-based measure, suggest-
ing ICECAP-A and EQ-5D-3L were measuring 2 dif-
ferent constructs, producing different but comple-
mentary information, a result which was further
supported by Engel et al.84 (comparing ICECAP-A
and EQ-5D-5L) and Davis et al.36 (comparing
ICECAP-O and EQ-5D-3L). This study indicates that
it is not possible to produce a robust mapping algo-
rithm based on the conceptual and design differ-
ences of the ICECAP-O and EQ-5D-3L.
Together with previous studies,36,83,84 this study
questions whether the measures conceptually
overlap sufficiently in their descriptive systems to
support the face validity of using a mapping algo-
rithm.41 The 2 measures operate on different numeri-
cal and conceptual scales. For descriptive purposes,
assume that a value of zero is equivalent across both
scales (i.e., a state equivalent to ‘‘dead’’ is the same
as ‘‘no capability’’; although, conceptually, ‘‘no capa-
bility’’ might not be the same as ‘‘dead’’). It is logical
to assume that, as health declines, so does capability
(this hypothesis is supported by the results in this
study) up to the point where a value of zero is
reported across both measures (i.e., a state equivalent
to dead is equal to no capability). This assumption is
conceptually possible but practically could never
happen, because zero is not an achievable EQ-5D-3L
tariff score. However, when using the EQ-5D-3L,
health can decline into negative values (or ‘‘states
worse than dead’’) but there are no negative values
for the ICECAP-O (i.e., there are no assumed negative
capability states). In this case, it is quite possible for
a person to be in ‘‘a state worse than dead’’ (e.g.,
20.2) and have a positive value of capability (e.g.,
0.2), while still assuming that the values of zero
across both scales are equivalent; conceptually this
is illogical and adds further concern to producing
and using a mapping algorithm.
The methods used to generate the available tariff
scores for the 2 measures, ICECAP-O and EQ-5D-3l,
best-worst scaling55 and time–trade-off,65 respec-
tively, did not account for the impact of time or
anchoring in an equivalent way. Brazier et al.85 pro-
vide a useful discussion about these issues when
Table 6 Best Performing Regression Model Quantifying the Link between ICECAP-O Capability Index and
the EQ-5D-3L Item Scores and Covariates (OLS Model 7)
Variable Description Equation Notation Coefficient
Standard
Error (SE)
95% Confidence
Interval P Value
Age Age of the patient age 20.002 0.001 20.004 to 0.000 0.097
Female Gender female 0.009 0.014 20.019 to 0.037 0.513
Care home Care home resident carehome 20.051 0.019 20.088 to 20.014 0.007
Mobility EQ-5D-3L domain
Some problem Level 2 s_mo 20.016 0.018 20.052 to 0.021 0.398
Extreme problem Level 3 e_mo 0.010 0.038 20.065 to 0.085 0.788
Self-care EQ-5D-3L domain
Some problem Level 2 s_sc 20.081 0.018 20.116 to 20.047 0.000
Extreme problem Level 3 e_sc 20.159 0.037 20.208 to 20.109 0.000
Usual activities EQ-5D-3L domain
Some problem Level 2 s_ua 20.042 0.017 20.076 to 20.007 0.017
Extreme problem Level 3 e_ua 20.106 0.023 20.151 to 20.062 0.000
Pain/discomfort EQ-5D-3L domain
Some problem Level 2 s_pd 20.003 0.017 20.037 to 0.031 0.883
Extreme problem Level 3 e_pd 0.032 0.028 20.088 to 0.024 0.265
Anxiety/depression EQ-5D-3L domain
Some problem Level 2 s_ad 20.089 0.015 20.118 to 20.060 0.000
Extreme problem Level 3 e_ad 20.083 0.038 20.157 to 20.008 0.030
Constant Constant term N/A 1.044 0.083 0.881 to 1.206 0.000
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eliciting preference-based scales, which is beyond
the scope of this paper. Furthermore, the feasible
range of the scores and data scaling issues for each
outcome cause measurement issues when using
regression analysis. Practically, it is still feasible to
perform the regression analysis but the measurement
issues mean that, when estimating a mapping func-
tion from a larger scale to a smaller scale (i.e., 20.594
to one [EQ-5D-3L) or zero to one [ICECAP-O]), there
will be a corresponding change in the scale of the
coefficients but no change in statistical significance.
Therefore, in this instance the estimated coefficients
may be smaller, which will have implications when
quantifying and describing the relationship between
health and capability. This means that mapping
between measures and scales would not appropriately
account for the conceptual differences in terms of
what the scales and scores mean and their subsequent
application in economic evaluations.
This study suggested there was a substantial dif-
ference in the mean EQ-5D-3L score but a marginal
difference in the mean ICECAP-O score for the
MCOP dataset when compared with the general
population (0.53 v. 0.73 for EQ-5D-3L; 0.76 v. 0.82
for ICECAP-O). After simply rescaling to account for
the EQ-5D-3L tariff score scale (1/1.594 = 0.627), the
absolute difference in ICECAP-O and EQ-5D-3L
scores could be described as a factor of 2 (0.06 v.
0.13). This observed difference in scores relative to
the general population is logical and feasible. The
empirical literature supports that people tend to
adapt to their state of being (such as health),16,86,87
which indicates that although in a lower health
state, a person’s capability may start to move back
towards ‘‘normal’’ as they adapt to the health state
(where ‘‘normal’’ could be defined as the general
population scores in this instance), when compared
with the general population. For example, someone
in a wheelchair might have the ‘‘ability to achieve
independence’’ (an ICECAP-O domain), even
though their mobility is severely impaired (an EQ-
5D-3L domain). The impact of if, and how, people
adapt is an external factor that cannot easily be
understood or accounted for when using mapping
methods; this is likely to restrict the generalizability
of any estimated algorithm measuring the relation-
ship between health and capability-based measures.
The relatively low levels of health status and
capability in the MCOP dataset and the assump-
tions of the regression models used (e.g., OLS) will
also influence the robustness of the observed quan-
tified relationship between health and capability.
When assessing the validity of the quantified rela-
tionship using the 3 study samples independently,
performance of the models improved when using
the AMOS dataset (patients with relatively better
quality of life than the overall MCOP sample) com-
pared with the MCOP dataset. Model performance
was generally not as good in the BMH and CHOS
datasets (patients with poorer quality of life than the
overall MCOP sample). This result is echoed in the
results assessing the performance of the best per-
forming model for estimating different parts of the
ICECAP-O tariff score distribution, whereby perfor-
mance worsened at the lower end of the tariff score
distribution; this suggests that the quantified rela-
tionship may not well explain the relationship
between poorer health and lower levels of capability.
Limitations and Recommendations for Future
Work
The estimation dataset used in this study was rel-
atively small compared with some previous mapping
studies.80,81 However, ‘‘successful mapping’’ (in
terms of better performance statistics) has been con-
ducted on smaller sample sizes.39,42,75 Furthermore,
there were no baseline ICECAP-O data in the avail-
able dataset, so it was not possible to assess the
potential sensitivity of the ICECAP-O to change over
time.
In terms of validation, the preferred method is to
use an external validation sample but this was not
feasible in this study.41 Validation of the regression
specification selected in this study was limited to
internal validation using 3 sub-groups defined a
priori. Other approaches to internal validation,
such as K-fold,88–91 could have been explored but
the impact of using this approach is a topic for
future research. During internal validation, the
poorest performance statistics were observed for
the CHOS sample. This could be attributed to: (i)
the use of proxy and self-responses within this
study, when previous studies have shown a discre-
pancy between proxy and self-response;92,93 (ii) the
nature of care homes and their residents (for exam-
ple, poor health and no other option [in relation to
informal or formal carers enabling community liv-
ing], forcing a need to live in a care home) may
change the relationship between health and capabil-
ity compared with their community-dwelling coun-
terparts for which the selected model specification
may be better suited.
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The EQ-5D-3L is a relatively specific measure of
generic health status. There are more comprehen-
sive (e.g., SF-3694) and condition-specific health
status (e.g., QLQ-C30 for cancer95) measures that
could have been compared with capability. A newer
alternative to the EQ-5D-3L, the EQ-5D-5L,96,97
which has 5 rather than 3 levels, is also recom-
mended by NICE.5 It was not possible to use EQ-5D-
5L in this study, as it was not ready for use during
the time period of the MCOP program’s studies.
People may respond differently to the EQ-5D-5L,98
leading to a redistribution of responses and there-
fore a change in how health is quantified and
described. Using the EQ-5D-5L could affect the
quantified relationship between capability and
health status. It is difficult to hypothesize the effect
this redistribution might have on the estimated rela-
tionship and this should be a focus for future
research. Other capability-based measures could
also be considered to further explore the relation-
ship between health status and capability, such as
ASCOT,99 OCAP-18,100 or OxCAP-MH101 measures.
Consistent with Makai et al.102, future studies
should assess the relationship between other
aspects of health and capability, particularly if these
constructs are to be used as objective endpoints by
which the effectiveness of interventions will be
judged within an economic evaluation.
A general limitation of the approach used in this
study was using OLS and CLAD models for com-
plex score distributions (for example, non-normally
distributed data with multiple peaks). The linear
aspect of these models potentially limited the extent
to which the estimated relationship captured the
impact over different points of the distribution of
the scores for the target measure within a defined
patient group. Additional model specifications,
such as mixture models to assess different aspects
of the distribution,75,77 could have been explored
but these models would still not compensate for the
inherent limitations in the available dataset. The
small number of patients with very low ICECAP-O
scores (\0.4; n = 33) in the MCOP dataset meant
that there may be too few observations to detect a
statistically significant association between lower
levels of health and capability. The small number of
low-score observations limits the production of a
robust algorithm at the lower levels of health and
capability using regression analysis, which is a lim-
itation for this study and other studies where it is
difficult to recruit patients with these low scores
(e.g., a low score is associated with poor health, and
poor health restricts a person’s ability to take part in
research). This limits the generalizability of the
quantified relationship to ‘‘all’’ older people (e.g.,
different co-morbidities and care consumption,
including medications) and other countries (e.g.,
those with different health and social care systems,
which may affect health and capability).
It was not possible to make causal inferences
about the relationship between the 2 constructs.
Establishing causal inferences would require fitting
regression models that contain different combina-
tions of 1 to 4 domains and interactions between
covariates (such as being in a care home and type of
care home) in a larger sample size with a wider dis-
tribution of outcome measure scores (i.e., more
lower level scores for both measures) than that
available in this study. Therefore, exploring causal
inferences could be the focus of future research but
would require a more suitable dataset.
CONCLUSION
A statistically significant association with capabil-
ity (measured using ICECAP-O) was identified for 3
(self-care, usual-activities, and anxiety/depression) of
the 5 EQ-5D-3L domains. Although health status was
found to be positively and directly associated with
capability, the strength of the association suggested
that it is not appropriate to use a mapping algorithm
to provide a link between the EQ-5D-3L and ICECAP-
O. This study demonstrated how the relationship
between health and capability can be assessed using
regression-based methods and adds further support to
previously published studies that a measure of capa-
bility, in this case, the ICECAP-O, is providing com-
plementary information rather than acting as a direct
substitute to a measure of health status.
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